Theragesic Cream
Pricing Report NDC 0178-0320-03

Latest NADAC: $0.03608 per GM · Effective Aug 21, 2019 · Est. package price $3.07 (85 GM)

Current Package Pricing Information

The latest wholesale acquisition cost for Theragesic (NDC 0178-0320-03) is $0.03608 per GM. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Aug 21, 2019.

As a a human over the counter drug provided by Mission Pharmacal Company, this medication is distributed in a 1 TUBE in 1 CARTON / 85 g in 1 TUBE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.03608
Per GM

Effective Date
Aug 21, 2019
Billable Units
85 GM
Estimated Package Price
$3.07
Data Status
As of Aug 12, 2020
C/I - Chain or Independent Pharmacy
Package NDC
Description
1 TUBE in 1 CARTON / 85 g in 1 TUBE
Pricing Methodology Explanation
The NADAC was carried forward from the previous file.
The NADAC was calculated based on package size.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Nov 2013, the NADAC wholesale price for (NDC ) has moved within a range of $0.03381 to $0.03899 per GM. Over this 5 years and 9 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.0338 - $0.0390
Market Volatility
15.32% Variance
Latest Trend
3.24%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Aug 21, 2019 $0.03608 GMC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Aug 21, 2019 $0.03608 GMC/I - Chain or Independent PharmacyCode 2, 5, 6B - Brand
Aug 21, 2019 $0.03608 GMC/I - Chain or Independent PharmacyCode 4, 5, 6B - Brand
May 22, 2019 $0.03729 GMC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
May 22, 2019 $0.03729 GMC/I - Chain or Independent PharmacyCode 2, 5, 6B - Brand
May 22, 2019 $0.03729 GMC/I - Chain or Independent PharmacyCode 4, 5, 6B - Brand
Apr 17, 2019 $0.03651 GMC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Apr 18, 2018 $0.03609 GMC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Apr 18, 2018 $0.03609 GMC/I - Chain or Independent PharmacyCode 2, 5, 6B - Brand
Apr 18, 2018 $0.03609 GMC/I - Chain or Independent PharmacyCode 4, 5, 6B - Brand
Mar 21, 2018 $0.03800 GMC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Dec 20, 2017 $0.03525 GMC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 5: The NADAC was calculated based on package size.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026